Nephros Statistics
Total Valuation
Nephros has a market cap or net worth of $16.45 million. The enterprise value is $15.80 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Nephros has 10.54 million shares outstanding. The number of shares has increased by 1.53% in one year.
Current Share Class | 10.54M |
Shares Outstanding | 10.54M |
Shares Change (YoY) | +1.53% |
Shares Change (QoQ) | +0.68% |
Owned by Insiders (%) | 12.34% |
Owned by Institutions (%) | 6.49% |
Float | 5.64M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.23 |
Forward PS | 4.47 |
PB Ratio | 2.05 |
P/TBV Ratio | 2.46 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.17 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.18.
Current Ratio | 6.95 |
Quick Ratio | 3.92 |
Debt / Equity | 0.18 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -480.00 |
Financial Efficiency
Return on equity (ROE) is -11.06% and return on invested capital (ROIC) is -6.29%.
Return on Equity (ROE) | -11.06% |
Return on Assets (ROA) | -5.63% |
Return on Capital (ROIC) | -6.29% |
Revenue Per Employee | $436,968 |
Profits Per Employee | -$29,968 |
Employee Count | 31 |
Asset Turnover | 1.27 |
Inventory Turnover | 1.97 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.44% in the last 52 weeks. The beta is 1.19, so Nephros's price volatility has been higher than the market average.
Beta (5Y) | 1.19 |
52-Week Price Change | -22.44% |
50-Day Moving Average | 1.58 |
200-Day Moving Average | 2.11 |
Relative Strength Index (RSI) | 54.89 |
Average Volume (20 Days) | 7,242 |
Short Selling Information
The latest short interest is 11,075, so 0.11% of the outstanding shares have been sold short.
Short Interest | 11,075 |
Short Previous Month | 626 |
Short % of Shares Out | 0.11% |
Short % of Float | 0.20% |
Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Nephros had revenue of $13.55 million and -$929,000 in losses. Loss per share was -$0.09.
Revenue | 13.55M |
Gross Profit | 8.27M |
Operating Income | -960,000 |
Pretax Income | -1.29M |
Net Income | -929,000 |
EBITDA | -804,000 |
EBIT | -960,000 |
Loss Per Share | -$0.09 |
Full Income Statement Balance Sheet
The company has $2.46 million in cash and $1.49 million in debt, giving a net cash position of $965,000 or $0.09 per share.
Cash & Cash Equivalents | 2.46M |
Total Debt | 1.49M |
Net Cash | 965,000 |
Net Cash Per Share | $0.09 |
Equity (Book Value) | 8.17M |
Book Value Per Share | 0.78 |
Working Capital | 6.30M |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 61.04%, with operating and profit margins of -7.09% and -6.86%.
Gross Margin | 61.04% |
Operating Margin | -7.09% |
Pretax Margin | -6.86% |
Profit Margin | -6.86% |
EBITDA Margin | -5.94% |
EBIT Margin | -7.09% |
FCF Margin | -6.70% |
Dividends & Yields
Nephros does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.53% |
Shareholder Yield | -1.53% |
Earnings Yield | -5.54% |
FCF Yield | n/a |
Analyst Forecast
The average price target for Nephros is $5.00, which is 220.51% higher than the current price. The consensus rating is "Buy".
Price Target | $5.00 |
Price Target Difference | 220.51% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 10, 2019. It was a reverse split with a ratio of 0.1111111:1.
Last Split Date | Jul 10, 2019 |
Split Type | Reverse |
Split Ratio | 0.1111111:1 |
Scores
Nephros has an Altman Z-Score of -11.03 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -11.03 |
Piotroski F-Score | 3 |